Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

Published:2010-09 Issue:5 Volume:10 Page:495-504
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Cole Claire,Lau Sin,Backen Alison,Clamp Andrew,Rushton Graham,Dive Caroline,Hodgkinson Cassandra,McVey Rhona,Kitchener Henry,Jayson Gordon C

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.10.5.12585

Reference18 articles.

1. Primary ovarian cancer chemotherapy: current standards of care

2. Developmental Localization of the Splicing Alternatives of Fibroblast Growth Factor Receptor-2 (FGFR2)

3. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples

4. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primer on fibroblast growth factor 7 (FGF 7);Differentiation;2024-09

2. Comprehensive Genomic Characterization in Ovarian Low-Grade and Chemosensitive and Chemoresistant High-Grade Serous Carcinomas;Oncology;2024-05-03

3. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones;Nature Communications;2024-04-03

4. The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression;Cancer Cell International;2024-01-25

5. Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment;Frontiers in Genetics;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3